Published September 2, 2025
| Version v1
Report
Open
U.S. Insulin Pump Market Demand, Size, Share, Growth, and Forecast 2032
Authors/Creators
Description
The U.S. insulin pump market is projected to grow from $2.98 billion in 2023 to $8.53 billion by 2030, with a compound annual growth rate of 16.2%. Key market drivers include:
- Rising type 1 diabetes prevalence, with an estimated 350,000 insulin pump users in the U.S. (90% type 1 diabetes, 10% type 2)
- Growing adoption of diabetes management technologies like continuous glucose monitors (CGM) and automated insulin delivery systems
- Strategic collaborations between companies, such as Eli Lilly partnering with Ypsomed for automated insulin delivery systems
Major market players include:
- Medtronic
- Tandem Diabetes Care
- Insulet Corporation
- ViCentra B.V.
- F. Hoffmann-La Roche Ltd
Key challenges include:
- COVID-19 impact causing decreased product sales and diabetes diagnoses in 2020
- Adverse events, with FDA reports showing a 224% increase in pump-related incidents from 2016-2021
- Disparities in access across racial and socioeconomic groups
The market is segmented by:
- Product type (pumps and consumables)
- Disease indication (type 1 and type 2 diabetes)
- Distribution channel (hospital pharmacy, retail & online pharmacy)
Report-
Fortune Business Insights - U.S. Insulin Pump Market Size | Growth Analysis Report [2030]
https://www.fortunebusinessinsights.com/u-s-insulin-pump-market-107534